In adolescents and adults, Szefler et al confirmed that the addition of FeNO measurement as an indicator of bronchial asthma Regulate resulted in greater doses of ICS and prolonged-acting ?2 agonists than did standard guideline-dependent therapy, and didn't establish improvements in asthma signs or symptoms or lung operate [105]. A current meta-Inv